By
Dr.Elza
Emmannual
ALPHA ADRENERGIC
BLOCKERS
CLASSIFICATION
REVERSIBLE NONSELECTIVE
ALPHA BLOCKERS
PHENTOLAMINE AND TOLAZOLINE
 Competitive Antagonist
CARDIOVASCULAR EFFECTS
Alpha 1 receptor blockade at the periphery
VASODILATATION
DECREASED PERIPHERAL
RESISTANCE
HYPOTENSION
HYPOTENSION
BARORECEPTOR REFLEX
SYMPATHETIC DISCHARGE
STIMULATION OF BETA 1 RECEPTORS OF
HEART
TACHYCARDIA ,PALPITATION
 EPISODES OF POSTURAL HYPOTENSION
 Due to absence of efficient peripheral
vasoconstriction in erect posture due to alpha 1
blockade → peripheral pooling of blood → cerebral
hypoxia,vertigo,fainting
 DALE’S VASOMOTOR REVERSAL
PHENOMENON - Prior treatment with alpha1
blocker prevents pressor response of epinephrine
,hence the unopposed vasodilating beta 2 effect is
observed.
OTHER EFFECTS
 Nasal stuffiness – vasodilatation & congestion of
nasal mucosa
 Miosis – Due to loss of tone of radial muscles of
iris
 Improved urine flow rates-due to smooth muscle
relaxation of bladder neck & prostate
 Failure of ejaculation & impotence-due to
inhibition of contraction of vas deferens &
ejaculatory ducts.
 Nausea,vomiting,diarrhoea
THERAPEUTIC USES
 Administered as IV
 For diagnosis & management of
PHEOCHROMOCYTOMA - If after giving 5mg of
phentolamine,BP falls by 25-35mm of Hg,it is a
potential case of pheochromocytoma & if it is less it is
a case of essential hypertension.
 PVD- Raynaud’s syndrome & frostbite
 To prevent dermal necrosis – can be used
locally(S.C.)to prevent dermal necrosis after incidental
extravasation of NE from IV infusion.
 To treat HYPERTENSIVE CRISIS that follows abrupt
withdrawal of clonidine or those resulting from
interaction of ingested tyramine containing food with
MAO inhibitors.
IRREVERSIBLE NONSELECTIVE
ALPHA BLOCKERS
PHENOXYBENZAMINE
 Binds covalently to alpha 1 & alpha 2 receptors
causing irreversible blockade for longer
duration
 Also inhibit reuptake of release noradrenaline by
adrenergic nerve terminals
 Preferred drug for pheochromocytoma
 Marked postural hypotension with initial first few
doses – first dose phenomenon,tolerance
develops later.
 Other toxic effects- reversible inhibition of
ejaculation,salt & water retention,cardiac
arrhythmias,sedation,fatigue & nausea.
USES
 Treatment of pheochromocytoma- controls
episodes of severe hypertension during surgical
manipulation.- 1mg/kg as i.v infusion.
 PVD-Raynauds phenomenon & frostbite.
REVERSIBLE SELECTIVE ALPHA
1 BLOCKERS
PRAZOSIN
 Less tachycardia as it lacks alpha 2 receptor
blocking actions,decreases cardiac preload,it
suppresses sympathetic outflow from CNS.
 Potent inhibitor of cyclic phosphodiesterase
enzyme causing rise in cAMP
 Causes rise in HDL & adecrease in LDL & TGL
 Relaxes smooth muscle in bladder
neck,prostatic capsule &prostatic urethra &
improves urine flow in BPH.
THERAPEUTIC USES
 Well absorbed orally.
 Treatment of hypertension- initial dose -1mg at
bedtime
 Treatment of BPH- 1-5mg orally BD
 Treatment of Raynauds disease.
TERAZOSIN & DOXAZOSIN
 Long duration of action
 Terazosin 2-5mg orally OD
 Doxazoin 1 – 4 mg OD
 More effective than fenasteride due to faster action
to decerease urine flow.
 Combination is better as it decreases prostate
volume.
BUNAZOSIN & ALFUZOSIN
 Both are orally effective
 Alfuzosin – 2.5mg TID,has to be avoided in patients
with hepatic impairment.
 Bunazosin- longer t1/2
TAMSULOSIN & SILODOSIN
 UROSELECTIVE
 Selective alpha 1A receptor antagonist which are
primarily located on bladder neck & urethra.
 More effective for treatment of BPH.
 Better bioavailability than prazosin
 Side effect – abnormal ejaculation & intra – operative
floppy iris syndrome.
INDORAMINE & URAPADIL
 No clinical use
ALPHA 2 BLOCKERS
YOHIMBINE & IDAZOXAN
 Yohimbine – natural alkaloid from Pausinystalia
yohimbe.
 No established clinical role.
 Although efficacy not clearly established ,can be
used to treat male sexual dysfunction , diabetic
neuropathy & postural hypotension.
 Drug can abruptly reverse antihypertensive effect
of alpha 2 agonist like clonidine which is an
important drug interaction.
MISCELLANEOUS
ERGOT ALKALOID
 Ergotamine & dihydroergotamine
 Competitive alpha receptor blocking activity
 Also act as partial agonist at alpha receptors and
at 5HT2 receptors.
 Some of these are oxytocics or dopamine
receptor agonists
THANKYOU

Alpha blockers

  • 1.
  • 2.
  • 3.
    REVERSIBLE NONSELECTIVE ALPHA BLOCKERS PHENTOLAMINEAND TOLAZOLINE  Competitive Antagonist CARDIOVASCULAR EFFECTS Alpha 1 receptor blockade at the periphery VASODILATATION DECREASED PERIPHERAL RESISTANCE HYPOTENSION
  • 4.
    HYPOTENSION BARORECEPTOR REFLEX SYMPATHETIC DISCHARGE STIMULATIONOF BETA 1 RECEPTORS OF HEART TACHYCARDIA ,PALPITATION
  • 5.
     EPISODES OFPOSTURAL HYPOTENSION  Due to absence of efficient peripheral vasoconstriction in erect posture due to alpha 1 blockade → peripheral pooling of blood → cerebral hypoxia,vertigo,fainting  DALE’S VASOMOTOR REVERSAL PHENOMENON - Prior treatment with alpha1 blocker prevents pressor response of epinephrine ,hence the unopposed vasodilating beta 2 effect is observed.
  • 6.
    OTHER EFFECTS  Nasalstuffiness – vasodilatation & congestion of nasal mucosa  Miosis – Due to loss of tone of radial muscles of iris  Improved urine flow rates-due to smooth muscle relaxation of bladder neck & prostate  Failure of ejaculation & impotence-due to inhibition of contraction of vas deferens & ejaculatory ducts.  Nausea,vomiting,diarrhoea
  • 7.
    THERAPEUTIC USES  Administeredas IV  For diagnosis & management of PHEOCHROMOCYTOMA - If after giving 5mg of phentolamine,BP falls by 25-35mm of Hg,it is a potential case of pheochromocytoma & if it is less it is a case of essential hypertension.  PVD- Raynaud’s syndrome & frostbite  To prevent dermal necrosis – can be used locally(S.C.)to prevent dermal necrosis after incidental extravasation of NE from IV infusion.  To treat HYPERTENSIVE CRISIS that follows abrupt withdrawal of clonidine or those resulting from interaction of ingested tyramine containing food with MAO inhibitors.
  • 8.
    IRREVERSIBLE NONSELECTIVE ALPHA BLOCKERS PHENOXYBENZAMINE Binds covalently to alpha 1 & alpha 2 receptors causing irreversible blockade for longer duration  Also inhibit reuptake of release noradrenaline by adrenergic nerve terminals  Preferred drug for pheochromocytoma  Marked postural hypotension with initial first few doses – first dose phenomenon,tolerance develops later.  Other toxic effects- reversible inhibition of ejaculation,salt & water retention,cardiac arrhythmias,sedation,fatigue & nausea.
  • 9.
    USES  Treatment ofpheochromocytoma- controls episodes of severe hypertension during surgical manipulation.- 1mg/kg as i.v infusion.  PVD-Raynauds phenomenon & frostbite.
  • 10.
    REVERSIBLE SELECTIVE ALPHA 1BLOCKERS PRAZOSIN  Less tachycardia as it lacks alpha 2 receptor blocking actions,decreases cardiac preload,it suppresses sympathetic outflow from CNS.  Potent inhibitor of cyclic phosphodiesterase enzyme causing rise in cAMP  Causes rise in HDL & adecrease in LDL & TGL  Relaxes smooth muscle in bladder neck,prostatic capsule &prostatic urethra & improves urine flow in BPH.
  • 11.
    THERAPEUTIC USES  Wellabsorbed orally.  Treatment of hypertension- initial dose -1mg at bedtime  Treatment of BPH- 1-5mg orally BD  Treatment of Raynauds disease.
  • 12.
    TERAZOSIN & DOXAZOSIN Long duration of action  Terazosin 2-5mg orally OD  Doxazoin 1 – 4 mg OD  More effective than fenasteride due to faster action to decerease urine flow.  Combination is better as it decreases prostate volume.
  • 13.
    BUNAZOSIN & ALFUZOSIN Both are orally effective  Alfuzosin – 2.5mg TID,has to be avoided in patients with hepatic impairment.  Bunazosin- longer t1/2 TAMSULOSIN & SILODOSIN  UROSELECTIVE  Selective alpha 1A receptor antagonist which are primarily located on bladder neck & urethra.  More effective for treatment of BPH.  Better bioavailability than prazosin  Side effect – abnormal ejaculation & intra – operative floppy iris syndrome.
  • 14.
  • 15.
    ALPHA 2 BLOCKERS YOHIMBINE& IDAZOXAN  Yohimbine – natural alkaloid from Pausinystalia yohimbe.  No established clinical role.  Although efficacy not clearly established ,can be used to treat male sexual dysfunction , diabetic neuropathy & postural hypotension.  Drug can abruptly reverse antihypertensive effect of alpha 2 agonist like clonidine which is an important drug interaction.
  • 16.
    MISCELLANEOUS ERGOT ALKALOID  Ergotamine& dihydroergotamine  Competitive alpha receptor blocking activity  Also act as partial agonist at alpha receptors and at 5HT2 receptors.  Some of these are oxytocics or dopamine receptor agonists
  • 17.